Skip to main content

Scientific Advisory Board

Stephen Harrison, M.D.

Scientific Advisory Board Chair

Dr. Harrison is a Visiting Professor of Hepatology at the Radcliffe Department of Medicine, University of Oxford. He is also the Medical Director for Pinnacle Clinical Research and the President of Summit Clinical Research. Dr. Harrison is a peer-reviewer for more than 20 medical journals. He is internationally known for studies in hepatitis C and non-alcoholic fatty liver disease with more than 200 peer reviewed publications in these fields. Dr. Harrison previously served as a Professor of Medicine at the Uniformed Services University of the Health Sciences. Learn More >>

Philippe Gallay, Ph.D.

Scientific Advisory Board

Dr. Gallay is Professor, Department of Immunology and Microbial Science at the Scripps Research Institute in La Jolla (San Diego), California. Dr. Gallay holds a Swiss Federal Diploma (MS), from the Institute of Biochemistry, Epalinges, Switzerland and a PhD from Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.  Dr. Gallay’s research program examines the molecular basis of HIV, HCV, and HBV pathogenesis, including characterization of host proteins modulating viral replication, such as various cyclophilins (Host Targeting Antivirals). Learn More >>

Rohit Loomba, M.D. M.H.Sc.

Scientific Advisory Board

Dr. Rohit Loomba is a Professor of Medicine, Director of Hepatology, and Chief of the liver service line at the University of California at San Diego(UCSD). He is an internationally recognized thought leader in translational research and innovative, clinical trial design in NASH, and non-invasive assessment of liver disease using advanced imaging modalities. Dr. Loomba is the founding director of the UCSD NAFLD Research Center, which is one of the most well-funded clinical and translational research programs at UCSD. Learn More >>

Nikolai Naoumov, M.D., Ph.D.

Scientific Advisory Board

Nikolai Naoumov is a physician-scientist with a professional career spanning academia, clinical care, and drug development – all focused on liver diseases. He is Fellow of both the Royal College of Physicians (London) and the Royal College of Pathologists (UK). His research has integrated immunology, molecular biology, and translational medicine in elucidating virus-host interactions and mechanisms of liver injury. Learn More >>

Yury Popov, M.D., Ph.D.

Scientific Advisory Board

Yury Popov is an Associate Professor of Medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. He received an M.D. (1997) from Grodno State Medical School, Belarus, and Ph.D. in Biochemistry (2004) from Institute of Biochemistry, National Academy of Sciences of Belarus, and trained in translational liver fibrosis research as an international Sheila Sherlock EASL Fellow at the University of Erlangen-Nuremberg, Germany. Learn More >>

Vlad Ratziu, M.D., Ph.D.

Scientific Advisory Board

Vlad Ratziu is a Professor of Hepatology at Sorbonne University, and performs his hospital work at the Pitié-Salpêtrière Hospital and the Institute for Cardiometabolism and Nutrition (ICAN) in Paris, France. Professor Ratziu received his medical training at Paris Descartes University; he then completed a 2-year postdoctoral fellowship at the Liver Center at the University of California, San Francisco, CA, and went on to earn a doctoral degree from Paris Diderot University for his work on the pathophysiology of viral and metabolic liver fibrosis. Learn More >>